Publications by authors named "Wilhelm Bone"

Claim this Profile
D
Discovery and Characterization of BAY-184: A New Potent and Selective Acylsulfonamide-Benzofuran -Active KAT6AB Inhibitor.
Antonius Ter Laak, Roman C Hillig, Steven J Ferrara, Daniel Korr, Naomi Barak, Wilhelm Bone

J Med Chem· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling.
Keith Graham, Philip Lienau, Benjamin Bader, Stefan Prechtl, Jan Naujoks, Wilhelm Bone

Cell Chem Biol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Characterization of BAY 1214784, an Orally Available Spiroindoline Derivative Acting as a Potent and Selective Antagonist of the Human Gonadotropin-Releasing Hormone Receptor as Proven in a First-In-Human Study in Postmenopausal Women.
Olaf Panknin, Andrea Wagenfeld, Wilhelm Bone, Eckhard Bender, Katrin Nowak-Reppel

J Med Chem· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Damage Incorporated: Discovery of the Potent, Highly Selective, Orally Available ATR Inhibitor BAY 1895344 with Favorable Pharmacokinetic Properties and Promising Efficacy in Monotherapy and in Combination Treatments in Preclinical Tumor Models.
Ulrich Lücking, Lars Wortmann, Antje M Wengner, Julien Lefranc, Philip Lienau, Wilhelm Bone

J Med Chem· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of BUB1 Kinase by BAY 1816032 Sensitizes Tumor Cells toward Taxanes, ATR, and PARP Inhibitors and .
Gerhard Siemeister, Anne Mengel, Amaury E Fernández-Montalván, Wilhelm Bone, Jens Schröder

Clin Cancer Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies.
Carsten Möller, Wilhelm Bone, Arwed Cleve, Ulrich Klar, Andrea Rotgeri

ChemMedChem· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BAY 1002670: a novel, highly potent and selective progesterone receptor modulator for gynaecological therapies.
Andrea Wagenfeld, Wilhelm Bone, Wolfgang Schwede, Martin Fritsch, Oliver M Fischer

Hum Reprod· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
10th Summit Meeting consensus: recommendations for regulatory approval for hormonal male contraception.
Pertti Aaltonen, John K Amory, Richard A Anderson, Hermann M Behre, Gabriel Bialy, Wilhelm Bone

J Androl· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The sensitivity of murine spermiogenesis to miglustat is a quantitative trait: a pharmacogenetic study.
Wilhelm Bone, Charlotte M Walden, Martin Fritsch, Ulrike Voigtmann, Eckhard Leifke

Reprod Biol Endocrinol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis